BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24877630)

  • 1. Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes.
    Ben-awadh AN; Delgado-Calle J; Tu X; Kuhlenschmidt K; Allen MR; Plotkin LI; Bellido T
    Endocrinology; 2014 Aug; 155(8):2797-809. PubMed ID: 24877630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
    Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
    J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.
    Rhee Y; Bivi N; Farrow E; Lezcano V; Plotkin LI; White KE; Bellido T
    Bone; 2011 Oct; 49(4):636-43. PubMed ID: 21726676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production.
    Delgado-Calle J; Hancock B; Likine EF; Sato AY; McAndrews K; Sanudo C; Bruzzaniti A; Riancho JA; Tonra JR; Bellido T
    FASEB J; 2018 May; 32(5):2878-2890. PubMed ID: 29401593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17 Receptor Signaling in Osteoblasts/Osteocytes Mediates PTH-Induced Bone Loss and Enhances Osteocytic RANKL Production.
    Li JY; Yu M; Tyagi AM; Vaccaro C; Hsu E; Adams J; Bellido T; Weitzmann MN; Pacifici R
    J Bone Miner Res; 2019 Feb; 34(2):349-360. PubMed ID: 30399207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.
    Saini V; Marengi DA; Barry KJ; Fulzele KS; Heiden E; Liu X; Dedic C; Maeda A; Lotinun S; Baron R; Pajevic PD
    J Biol Chem; 2013 Jul; 288(28):20122-34. PubMed ID: 23729679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
    Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
    J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
    Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
    PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIKs control osteocyte responses to parathyroid hormone.
    Wein MN; Liang Y; Goransson O; Sundberg TB; Wang J; Williams EA; O'Meara MJ; Govea N; Beqo B; Nishimori S; Nagano K; Brooks DJ; Martins JS; Corbin B; Anselmo A; Sadreyev R; Wu JY; Sakamoto K; Foretz M; Xavier RJ; Baron R; Bouxsein ML; Gardella TJ; Divieti-Pajevic P; Gray NS; Kronenberg HM
    Nat Commun; 2016 Oct; 7():13176. PubMed ID: 27759007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTH (1-34) affects bone turnover governed by osteocytes exposed to fluoride.
    Yu X; Yu H; Jiang N; Zhang X; Zhang M; Xu H
    Toxicol Lett; 2018 May; 288():25-34. PubMed ID: 29447955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency.
    Xiong J; Piemontese M; Thostenson JD; Weinstein RS; Manolagas SC; O'Brien CA
    Bone; 2014 Sep; 66():146-54. PubMed ID: 24933342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
    Piemontese M; Xiong J; Fujiwara Y; Thostenson JD; O'Brien CA
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E587-93. PubMed ID: 27460899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pannexin-1 and P2X7-Receptor Are Required for Apoptotic Osteocytes in Fatigued Bone to Trigger RANKL Production in Neighboring Bystander Osteocytes.
    Cheung WY; Fritton JC; Morgan SA; Seref-Ferlengez Z; Basta-Pljakic J; Thi MM; Suadicani SO; Spray DC; Majeska RJ; Schaffler MB
    J Bone Miner Res; 2016 Apr; 31(4):890-9. PubMed ID: 26553756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor.
    Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T
    J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid Hormone Induces Bone Cell Motility and Loss of Mature Osteocyte Phenotype through L-Calcium Channel Dependent and Independent Mechanisms.
    Prideaux M; Dallas SL; Zhao N; Johnsrud ED; Veno PA; Guo D; Mishina Y; Harris SE; Bonewald LF
    PLoS One; 2015; 10(5):e0125731. PubMed ID: 25942444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation.
    Marahleh A; Kitaura H; Ohori F; Kishikawa A; Ogawa S; Shen WR; Qi J; Noguchi T; Nara Y; Mizoguchi I
    Front Immunol; 2019; 10():2925. PubMed ID: 31921183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Notch pathway regulates the bone gain induced by PTH anabolic signaling.
    Delgado-Calle J; McAndrews K; Wu G; Orr AL; Ferrari A; Tu X; Srinivasan V; Roodman GD; Ebetino FH; Boeckman RK; Bellido T
    FASEB J; 2022 Mar; 36(3):e22196. PubMed ID: 35137455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of osteocyte-derived RANKL on bone graft remodeling: An in vivo experimental study.
    Feher B; Kampleitner C; Heimel P; Tangl S; Helms JA; Kuchler U; Gruber R
    Clin Oral Implants Res; 2023 Dec; 34(12):1417-1427. PubMed ID: 37792417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsed electromagnetic fields regulate osteocyte apoptosis, RANKL/OPG expression, and its control of osteoclastogenesis depending on the presence of primary cilia.
    Wang P; Tang C; Wu J; Yang Y; Yan Z; Liu X; Shao X; Zhai M; Gao J; Liang S; Luo E; Jing D
    J Cell Physiol; 2019 Jul; 234(7):10588-10601. PubMed ID: 30422320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.